Literature DB >> 1402669

Immunoglobulin M and D antigen receptors are both capable of mediating B lymphocyte activation, deletion, or anergy after interaction with specific antigen.

R Brink1, C C Goodnow, J Crosbie, E Adams, J Eris, D Y Mason, S B Hartley, A Basten.   

Abstract

A series of immunoglobulin (Ig)-transgenic mice were generated to study the functional capabilities of the IgM and IgD classes of B lymphocyte antigen receptor in regulating both cellular development and responses to specific antigen. B cells from Ig-transgenic mice expressing either hen-egg lysozyme (HEL)-specific IgM or IgD alone were compared with B cells from mice that coexpressed IgM and IgD of the same anti-HEL specificity. In all three types of Ig-transgenic mice, conventional B cells specific for HEL exhibited exclusion of endogenous Ig expression and matured to populate the usual microenvironments in peripheral lymphoid tissues. These peripheral B cells could be stimulated by HEL through either IgM or IgD antigen receptors to generate T cell dependent antibody production in vivo or to enhance T cell independent proliferative responses to lipopolysaccharide in vitro. Conversely, when HEL was encountered in vivo as a self-antigen, B cells expressing HEL-specific IgM or IgD alone were both rendered tolerant. In each case this occurred by clonal anergy in response to soluble autologous HEL, and clonal deletion when HEL was recognized as a membrane-bound self-antigen. Taken together, these findings indicate that IgM and IgD antigen receptors expressed alone on conventional B cells can support normal differentiation, antigen-dependent activation, and induction of self-tolerance, the only overt difference lying in a greater degree of receptor downregulation for IgM relative to IgD after induction of clonal anergy by soluble HEL.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1402669      PMCID: PMC2119398          DOI: 10.1084/jem.176.4.991

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  61 in total

1.  Identification of the genes encoding the IgM-alpha and Ig-beta components of the IgM antigen receptor complex by amino-terminal sequencing.

Authors:  J Hombach; F Lottspeich; M Reth
Journal:  Eur J Immunol       Date:  1990-12       Impact factor: 5.532

2.  The Ly-1 B cell lineage.

Authors:  L A Herzenberg; A M Stall; P A Lalor; C Sidman; W A Moore; D R Parks; L A Herzenberg
Journal:  Immunol Rev       Date:  1986-10       Impact factor: 12.988

3.  Role of transcriptional termination in the regulation of mu mRNA expression in B lymphocytes.

Authors:  E A Weiss; A Michael; D Yuan
Journal:  J Immunol       Date:  1989-08-01       Impact factor: 5.422

4.  Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes.

Authors:  D A Nemazee; K Bürki
Journal:  Nature       Date:  1989-02-09       Impact factor: 49.962

Review 5.  Clonal silencing of self-reactive B lymphocytes in a transgenic mouse model.

Authors:  C C Goodnow; J Crosbie; S Adelstein; T B Lavoie; S J Smith-Gill; D Y Mason; H Jorgensen; R A Brink; H Pritchard-Briscoe; M Loughnan
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1989

6.  Isolation of high-affinity memory B cells: phycoerythrin as a probe for antigen-binding cells.

Authors:  K Hayakawa; R Ishii; K Yamasaki; T Kishimoto; R R Hardy
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

7.  Transcriptional regulation of mu and delta gene expression in bone marrow pre-B and B lymphocytes.

Authors:  D Yuan; P L Witte
Journal:  J Immunol       Date:  1988-04-15       Impact factor: 5.422

8.  Regulation of surface IgM- and IgD-mediated inositol phosphate formation and Ca2+ mobilization in murine B lymphocytes.

Authors:  M M Harnett; M J Holman; G G Klaus
Journal:  Eur J Immunol       Date:  1989-10       Impact factor: 5.532

9.  Major histocompatibility complex-restricted, polyclonal B cell responses resulting from helper T cell recognition of antiimmunoglobulin presented by small B lymphocytes.

Authors:  H P Tony; D C Parker
Journal:  J Exp Med       Date:  1985-01-01       Impact factor: 14.307

10.  A NEW CLASS OF HUMAN IMMUNOGLOBULINS. II. NORMAL SERUM IGD.

Authors:  D S ROWE; J L FAHEY
Journal:  J Exp Med       Date:  1965-01-01       Impact factor: 14.307

View more
  37 in total

1.  A differential requirement for phosphoinositide 3-kinase reveals two pathways for inducible upregulation of major histocompatibility complex class II molecules and CD86 expression by murine B lymphocytes.

Authors:  Stuart Marshall-Clarke; Lynn Tasker; Mark P Heaton; R Michael E Parkhouse
Journal:  Immunology       Date:  2003-05       Impact factor: 7.397

Review 2.  Models of signal transduction through the B-cell antigen receptor.

Authors:  Roland Geisberger; Reto Crameri; Gernot Achatz
Journal:  Immunology       Date:  2003-12       Impact factor: 7.397

Review 3.  Translational Mini-Review Series on B cell subsets in disease. Transitional B cells in systemic lupus erythematosus and Sjögren's syndrome: clinical implications and effects of B cell-targeted therapies.

Authors:  A Vossenkämper; P M K Lutalo; J Spencer
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

4.  Peripheral B cell tolerance and function in transgenic mice expressing an IgD superantigen.

Authors:  Bao Hoa Duong; Takayuki Ota; Djemel Aït-Azzouzene; Miyo Aoki-Ota; José Luis Vela; Christoph Huber; Kevin Walsh; Amanda L Gavin; David Nemazee
Journal:  J Immunol       Date:  2010-03-15       Impact factor: 5.422

Review 5.  The enigmatic function of IgD: some answers at last.

Authors:  Cindy Gutzeit; Kang Chen; Andrea Cerutti
Journal:  Eur J Immunol       Date:  2018-06-12       Impact factor: 5.532

6.  The protooncogene MYC can break B cell tolerance.

Authors:  Yosef Refaeli; Kenneth A Field; Brian C Turner; Andreas Trumpp; J Michael Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-07       Impact factor: 11.205

Review 7.  Understanding B-cell tolerance through the use of immunoglobulin transgenic models.

Authors:  Kirthi Raman Kumar; Chandra Mohan
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

8.  FcgammaRIIB signals inhibit BLyS signaling and BCR-mediated BLyS receptor up-regulation.

Authors:  Jenni E Crowley; Jason E Stadanlick; John C Cambier; Michael P Cancro
Journal:  Blood       Date:  2008-09-12       Impact factor: 22.113

9.  Anergic self-reactive B cells present self antigen and respond normally to CD40-dependent T-cell signals but are defective in antigen-receptor-mediated functions.

Authors:  J M Eris; A Basten; R Brink; K Doherty; M R Kehry; P D Hodgkin
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

10.  Modulation of peripheral B cell tolerance by CD72 in a murine model.

Authors:  Daniel Hsieh-Hsin Li; Monte M Winslow; Thai M Cao; Albert H Chen; Corrine R Davis; Elizabeth D Mellins; Paul J Utz; Gerald R Crabtree; Jane R Parnes
Journal:  Arthritis Rheum       Date:  2008-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.